P479: DNA METHYLATION PROFILING REFINES THE PROGNOSTIC CLASSIFICATION OF ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH INTENSIVE CHEMOTHERAPY

• S. Vosberg,
• A. Ohnmacht,
• C. Moser,
• A. Arneth,
• V. Jurinovic,
• K. H. Metzeler,
• M. C. Sauerland,
• D. Görlich,
• W. E. Berdel,
• J. Braess,
• S. Amler,
• U. Krug,
• W. Hiddemann,
• K. Spiekermann,
• C. C. Oakes,
• M. P. Menden,
• T. Herold,
• P. A. Greif

Affiliations

S. Vosberg

1 Department of Internal Medicine, Medical University of Graz, Graz, Austria

A. Ohnmacht

2 Institute of Computational Biology, Helmholtz Zentrum Munich, Neuherberg

C. Moser

3 Department of Medicine III, University Hospital LMU Munich, Munich

A. Arneth

2 Institute of Computational Biology, Helmholtz Zentrum Munich, Neuherberg

V. Jurinovic

3 Department of Medicine III, University Hospital LMU Munich, Munich

K. H. Metzeler

4 Department of Hematology, Cellular Therapy, and Hemostaseology, University of Leipzig, Leipzig

M. C. Sauerland

5 Institute of Biostatistics and Clinical Research

D. Görlich

5 Institute of Biostatistics and Clinical Research

W. E. Berdel

6 Department of Medicine, Hematology and Oncology, University of Münster, Münster

J. Braess

7 Department of Oncology and Hematology, Hospital Barmherzige Brüder, Regensburg

S. Amler

8 Friedrich-Loeffler-Institut, Greifswald-Insel Riems

U. Krug

9 Department of Medicine III, Hospital Leverkusen, Leverkusen, Germany

W. Hiddemann

3 Department of Medicine III, University Hospital LMU Munich, Munich

K. Spiekermann

3 Department of Medicine III, University Hospital LMU Munich, Munich

C. C. Oakes

10 Department of Internal Medicine, The Ohio State University, Columbus, United States of America

M. P. Menden

2 Institute of Computational Biology, Helmholtz Zentrum Munich, Neuherberg

T. Herold

3 Department of Medicine III, University Hospital LMU Munich, Munich

P. A. Greif

3 Department of Medicine III, University Hospital LMU Munich, Munich